Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/22/2003US20030095927 Provides biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect.
05/22/2003US20030095926 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
05/22/2003US20030095925 For rapid absorption through the oral mucosa, resulting in fast onset of effect.
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2467424A1 Treatment of inflammatory conditions
05/22/2003CA2467391A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
05/22/2003CA2467347A1 Histamine receptor h3 polynucleotides
05/22/2003CA2467264A1 N-methyl-homocystines, use thereof and method for the production thereof
05/22/2003CA2467258A1 Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same and use of the same.
05/22/2003CA2467239A1 Catheter injectable depot compositions and uses thereof
05/22/2003CA2466998A1 Biocompatible polymer blends and uses thereof
05/22/2003CA2466701A1 Neuroprotective use of cyclic prolyl glycine
05/22/2003CA2466659A1 Anticancer agents
05/22/2003CA2466632A1 Injectable depot compositions and uses thereof
05/22/2003CA2466592A1 Modified anti-tnf alpha antibody
05/22/2003CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003CA2466346A1 Single nucleotide polymorphisms in gh-1
05/22/2003CA2466279A1 Agents that modulate immune cell activation and methods of use thereof
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2465304A1 Composition comprising inhibitors of the notch signalling pathway for the modulation of the immune system
05/22/2003CA2465080A1 Peptide derivative and pharmaceutically acceptable salts thereof, and production process and use thereof
05/22/2003CA2461481A1 Ptp1b inhibitors and ligands
05/22/2003CA2460959A1 Enzymes
05/21/2003EP1312675A1 Protein induced by homogeneous blood transfusion and dna encoding the same
05/21/2003EP1312612A1 Cyclic peptide derivative
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312383A2 Resorbable extracellular matrix containing collagen I and collagen II for reconstruction of cartilage
05/21/2003EP1312378A1 Agents for ameliorating symptoms caused by joint diseases
05/21/2003EP1312376A1 Vascular relaxation agents
05/21/2003EP1312363A1 Methods of treatment and kits comprising a growth hormone secretagogue
05/21/2003EP1311704A2 Novel target genes for diseases of the heart
05/21/2003EP1311699A2 Adeno-associated virus-mediated delivery of angiogenic factors
05/21/2003EP1311691A2 Method and compositions for promoting osteogenesis
05/21/2003EP1311689A2 Human carboxylesterase family member and uses thereof
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
05/21/2003EP1311678A2 Cripto tumour polypeptide
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311675A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311672A1 New sequences
05/21/2003EP1311669A1 11 human secreted proteins
05/21/2003EP1311666A2 Progression suppressed gene 13 (psgen 13) and uses thereof
05/21/2003EP1311665A2 Kidney-specific protein
05/21/2003EP1311664A2 Microtubule-associated proteins and tubulins
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311660A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4
05/21/2003EP1311547A2 Diagnosis and treatment of cardiovascular conditions
05/21/2003EP1311543A1 T cell receptor v beta-d beta-j beta sequence and methods for its detection
05/21/2003EP1311542A2 Peptide selection method
05/21/2003EP1311541A1 IMMUNOGENIC PROTEINS DERIVED FROM DOMESTIC MITE ALLERGEN, BLOMIA TROPICALIS (Bt5)
05/21/2003EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
05/21/2003EP1311538A2 Inhibitors of hiv replication and method of treatment of hiv infections
05/21/2003EP1311537A2 Identification of a cam-kinase ii inhibitor
05/21/2003EP1311536A2 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1311298A2 System for regulating in vivo the expression of a transgene by conditional inhibition
05/21/2003EP1311297A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual
05/21/2003EP1311292A2 Vitronectin receptor antagonist pharmaceuticals
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311290A2 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
05/21/2003EP1311289A2 Vaccines containing ribavirin and methods of use thereof
05/21/2003EP1311287A2 Transglutaminase for inhibiting angiogenesis
05/21/2003EP1311286A1 Treatment of hepatitis c with thymosin and pegylated interferon
05/21/2003EP1311285A2 Liquid pharmaceutical composition containing an erythropoietin derivative
05/21/2003EP1311284A2 Saratin for inhibiting platelet adhesion to collagen
05/21/2003EP1311283A2 Omega-conopeptides
05/21/2003EP1311282A1 High affinity integrin polypeptides and uses thereof
05/21/2003EP1311281A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
05/21/2003EP1311279A1 Treatment of hepatitis c with thymosin, interferon and ribavirin
05/21/2003EP1311278A1 Method and composition for immunization using mixed pools of mutated nucleic acids or peptides
05/21/2003EP1311277A1 Methods of modulating fibrosis
05/21/2003EP1311262A1 Cancer treatment by combination therapy
05/21/2003EP1311255A1 Compounds having mif antagonist activity
05/21/2003EP1311252A2 Treatment of wounds
05/21/2003EP1311241A2 Use of a porous carrier
05/21/2003EP1311239A1 Oral delivery of peptide
05/21/2003EP1233775B1 Tyrosine- and tryptophan-containing peptides as antioxidants
05/21/2003EP1204675B1 Streptogramin derivatives, production thereof and compositions containing the same
05/21/2003EP1189932B1 Novel echinocandin derivatives, method for preparing the same and use as antifungal agents
05/21/2003EP1144003A4 Methods and devices for delivery of agents to breast milk ducts
05/21/2003EP1140976A4 Secreted proteins and uses thereof
05/21/2003EP1017367B1 Methods for fabricating polymer-based controlled release preparations
05/21/2003EP1015593B1 Hepatitis b virus polypeptides
05/21/2003EP0996468B1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
05/21/2003EP0993303B1 Substances in order to achieve preference and create acceptance
05/21/2003EP0988042A4 A combination therapy for hiv infections
05/21/2003EP0878200B1 Therapeutic agent for ophthalmic diseases
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0845939B1 Lysosomal proteins produced in the milk of nonhuman transgenic animals
05/21/2003EP0820285B1 Methods and compositions for lipidization of hydrophilic molecules
05/21/2003EP0769959B1 Anti-protozoan methods and materials
05/21/2003EP0765166B1 Radiolabeled annexin-galactose conjugates
05/21/2003EP0633931B1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
05/21/2003EP0575545B1 Pegylation of polypeptides
05/21/2003EP0554385B1 Cloning and expression of biologically active alpha-n-acetylgalactosaminidase
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
1 ... 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 ... 3163